Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project
Presager II
1 other identifier
observational
400
1 country
1
Brief Summary
In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8. Secondary endpoints:
- An artificial intelligence model's precision in predicting a new flare within 2 and 3 years
- An artificial intelligence model's precision to rule out patients who will not experience a new flare within 1, 2 and 3 year
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2022
CompletedFirst Submitted
Initial submission to the registry
June 29, 2022
CompletedFirst Posted
Study publicly available on registry
July 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedFebruary 27, 2025
February 1, 2025
3.5 years
June 29, 2022
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Flare I
Evaluate the accuracy in predicting a flare within 1 year after the patient's initial flare using machine learning methods.
within 1 year
Secondary Outcomes (2)
Flare II
within 2 years
Flare III
within 3 years
Interventions
Use of deep learning model to predict individual patients disease course
Eligibility Criteria
This is a prospective cohort of a total of 400 UC patients with an active flare
You may qualify if:
- Signed informed consent
- Diagnosis of UC for at least 1 year
- Relapse due to UC.
You may not qualify if:
- Well-founded doubt that the flare is due to other than the patients UC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gastrounit, medical section, Copenhagen University Hospital Hvidovre
Hvidovre, Denmark, 2650, Denmark
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 29, 2022
First Posted
July 29, 2022
Study Start
June 20, 2022
Primary Completion
December 1, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
February 27, 2025
Record last verified: 2025-02